Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-89.20M
↓ 114% below average
Average (4y)
$-41.69M
Historical baseline
Range
High:$-3.17M
Low:$-89.20M
CAGR
+130.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-89.20M | -32.7% |
| 2023 | $-67.24M | -105.9% |
| 2022 | $-32.66M | -101.8% |
| 2021 | $-16.18M | -410.9% |
| 2020 | $-3.17M | - |